Proposal for a new model of breast cancer metastatic development (Q41679425)

7 October 2017

1 reference

title

Proposal for a new model of breast cancer metastatic development (English)

1 reference

7 October 2017

R Demicheli

1

1 reference

7 October 2017

M W Retsky

series ordinal

2

1 reference

7 October 2017

D E Swartzendruber

series ordinal

3

1 reference

7 October 2017

G Bonadonna

series ordinal

4

1 reference

7 October 2017

publication date

1 November 1997

1 reference

7 October 2017

1 reference

7 October 2017

volume

8

1 reference

7 October 2017

issue

11

1 reference

7 October 2017

page(s)

1075-1080

1 reference

Local-regional breast cancer recurrence following mastectomy

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

The value of prognostic parameters for the stratification of advanced breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

The metastasis-free interval following curative treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Screening for recurrent breast cancer--its effectiveness and prognostic value.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Human breast cancer: survival from first metastasis. Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Survival of patients with relapsing breast cancer: analysis of 302 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Survival after first recurrence of breast cancer. The Miami experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Treatment of relapse of breast cancer after adjuvant systemic therapy--review and guidelines for future research

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Survival after first recurrence in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Local Recurrences Following Mastectomy: Support for the Concept of Tumor Dormancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

The biology and natural history of breast cancer from the screening perspective

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Interval cancer and survival in a randomized breast cancer screening trial in Stockholm

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Dormancy and breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Metastasis suppressor genes.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

DYNAMICS OF TUMOR GROWTH

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Salvage treatments in relapsing resectable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Relationship between disease-free interval and survival in patients with recurrent melanoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263116022

7 January 2021

Identifiers

DOI

10.1023/A:1008263116022

1 reference

7 October 2017

1 reference